Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 1.221M
March 31, 2026 8.882M
December 31, 2025 0.41M
September 30, 2025 0.103M
June 30, 2025 0.392M
March 31, 2025 9.615M
December 31, 2024 13.83M
September 30, 2024 40.20M
June 30, 2024 0.472M
March 31, 2024 1.362M
December 31, 2023 15.58M
September 30, 2023 0.363M
June 30, 2023 0.473M
Date Value
March 31, 2023 7.568M
December 31, 2022 7.117M
September 30, 2022 0.007M
June 30, 2022 0.321M
March 31, 2022 0.048M
December 31, 2021 -21.29M
September 30, 2021 133.17M
June 30, 2021 0.00
March 31, 2021 0.002M
December 31, 2020 0.00
September 30, 2020 49.78M
June 30, 2020 0.00
March 31, 2020 0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
NeuroPace, Inc. 1.176M
Accuray, Inc. 3.624M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 2.236M
ResMed, Inc. -263.16M